Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy.
COVID-19
Coronavirus
Diabetes
Hyperglycemia
Oxidative stress
SARS-CoV-2
Journal
Primary care diabetes
ISSN: 1878-0210
Titre abrégé: Prim Care Diabetes
Pays: England
ID NLM: 101463825
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
08
11
2020
revised:
03
01
2021
accepted:
04
01
2021
pubmed:
14
1
2021
medline:
27
5
2021
entrez:
13
1
2021
Statut:
ppublish
Résumé
This review reported that coronavirus disease 2019 (COVID-19) infected patients with short time bed rest or quarantine and airway inflammation are at more risk of developing hyperglycemia and insulin resistance. This condition can induce oxidative stress, decrease immune system function, impair endothelial function, induce apoptosis, and reduce antioxidant in the lungs. We provide a possible mechanism in severe COVID-19 patients and recommend treatment strategy to reduce mortality rate and prevent adverse outcomes after intensive care unit (ICU).
Identifiants
pubmed: 33436320
pii: S1751-9918(21)00002-4
doi: 10.1016/j.pcd.2021.01.002
pmc: PMC7834268
pii:
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
409-416Informations de copyright
Copyright © 2021 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.